Gastrointestinal Cancer News

Promising results for a simple cheek swab test to detect precancerous lesions in lung cancer may signify an era of affordable first-line diagnostic procedures, according to researchers at Northwestern University.

OBI Pharma received FDA orphan drug designation for OBI-3424 for the treatment of hepatocellular carcinoma, according to a press release.

Researchers from the American Cancer Society identified trends in disparities and outcomes for cancer over the last few decades in an effort to highlight the need for better quality care for all individuals with cancer, according to a report published in CA: A Cancer Journal for Clinicians.

Treatment directed by current National Comprehensive Cancer Network guidelines for rectal cancer did not prolong OS among patients aged younger than 50 years, according to a retrospective review of the National Cancer Database published in Cancer.

Clonal hematopoiesis-related mutations appeared to be misinterpreted as solid tumors mutations when tumor-only sequencing was used for a variety of cancer types, according to results of a gene-sequencing study.

The Henry Ford Cancer Institute received a $20 million grant to fund the creation of a new multi-institutional pancreatic cancer research consortium.

Residents of ‘cold spots’ — deprived communities that lack essential opportunities for health — were more likely to have obesity, poor diabetes control, and less likely to undergo colon cancer screening, according to findings recently published in the Journal of the American Board of Family Medicine.

Patients with advanced liver cancer experienced clinical benefit with regorafenib after disease progression on sorafenib, according to findings published in Journal of Hepatology.

Patients with Barrett’s esophagus who took proton pump inhibitors or histamine-2 receptor antagonists had a lower risk for developing esophageal adenocarcinoma, according to research published in Alimentary Pharmacology & Therapeutics.

Adolescent and young adult cancer survivors had a higher than expected rate of hospital contact for endocrine diseases, including thyroid disease, testicular dysfunction and diabetes, according to a Danish population-based study.